{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:52:33Z","timestamp":1762660353104,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.039","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T12:50:58Z","timestamp":1686833458000},"page":"4693-4699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5283-3897","authenticated-orcid":false,"given":"Patrizia","family":"Pignatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Alvise","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3884-5562","authenticated-orcid":false,"given":"Marco","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Marraccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3560-9759","authenticated-orcid":false,"given":"Serena","family":"Nannipieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2963-9882","authenticated-orcid":false,"given":"Chiara","family":"Asperti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio Della","family":"Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Tiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice Maria","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Gurrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Meriggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4310-6951","authenticated-orcid":false,"given":"Giovanni","family":"Benanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Bernadette","family":"Cilona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Pigatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuele E.","family":"Burastero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7428-315X","authenticated-orcid":false,"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2417-0410","authenticated-orcid":false,"given":"Mona-Rita","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2023.06.039_b0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40259-022-00536-8","article-title":"Allergic reactions to COVID-19 vaccines: risk factors, frequency, mechanisms and management","volume":"36","author":"Luxi","year":"2022","journal-title":"BioDrugs"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.039_b0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021","volume":"70","author":"Team CC-R","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"10","key":"10.1016\/j.vaccine.2023.06.039_b0015","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/j.jaip.2022.08.010","article-title":"Assessment of immediate allergic reactions after immunization with the Pfizer BNT162b2 vaccine using intradermal skin testing with the COVID-19 vaccines","volume":"10","author":"Shavit","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.039_b0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2021.09.002","article-title":"Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study","volume":"86","author":"McMahon","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"10.1016\/j.vaccine.2023.06.039_b0025","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMc2102131","article-title":"Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2","volume":"384","author":"Blumenthal","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.039_b0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2500\/aap.2022.43.210101","article-title":"Delayed systemic urticarial reactions following mRNA COVID-19 vaccination","volume":"43","author":"Pitlick","year":"2022","journal-title":"Allergy Asthma Proc: Off J Regional State Allergy Societies"},{"issue":"12","key":"10.1016\/j.vaccine.2023.06.039_b0035","article-title":"Late hypersensitivity reactions to the BNT162b2 SARS-CoV-2 vaccine are linked to delayed skin sensitization and prior exposure to hyaluronic acid","volume":"12","author":"Maoz-Segal","year":"2022","journal-title":"Life (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.039_b0040","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2021.8515","article-title":"Risk of second allergic reaction to SARS-CoV-2 vaccines: a systematic review and meta-analysis","volume":"182","author":"Chu","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"44","key":"10.1016\/j.vaccine.2023.06.039_b0045","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2021.09.048","article-title":"Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine","volume":"39","author":"Yacoub","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2023.06.039_b0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22255","article-title":"Prevalence of allergic reactions after Pfizer-BioNTech COVID-19 vaccination among adults with high allergy risk","volume":"4","author":"Shavit","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.039_b0055","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ymthe.2021.01.030","article-title":"Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines","volume":"29","author":"Moghimi","year":"2021","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"issue":"7","key":"10.1016\/j.vaccine.2023.06.039_b0060","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.jaip.2019.05.058","article-title":"Polyethylene glycols and polysorbates: Two still neglected ingredients causing true IgE-mediated reactions","volume":"7","author":"Calogiuri","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.039_b0065","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13075-017-1396-8","article-title":"Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout","volume":"19","author":"Calabrese","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.vaccine.2023.06.039_b0070","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jaci.2016.04.058","article-title":"Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer","volume":"138","author":"Povsic","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2023.06.039_b0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system","volume":"4","author":"Warren","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.039_b0080","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.alit.2022.05.007","article-title":"Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines","volume":"71","author":"Mouri","year":"2022","journal-title":"Allergol Int: Off J Japanese Soc Allergol"},{"issue":"7","key":"10.1016\/j.vaccine.2023.06.039_b0085","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/all.15183","article-title":"Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis","volume":"77","author":"Brockow","year":"2022","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.vaccine.2023.06.039_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100541","article-title":"Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital","volume":"14","author":"Paoletti","year":"2021","journal-title":"World Allergy Organiz J"},{"issue":"16","key":"10.1016\/j.vaccine.2023.06.039_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23168838","article-title":"Monitoring anti-PEG antibodies level upon repeated lipid nanoparticle-based COVID-19 vaccine administration","volume":"23","author":"Guerrini","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.vaccine.2023.06.039_b0100","article-title":"Challenges to vaccination against SARS-CoV-2 in patients with immune-mediated diseases","volume":"9","author":"Ramirez","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.vaccine.2023.06.039_b0105","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/imj.15821","article-title":"Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine","volume":"52","author":"Hurst","year":"2022","journal-title":"Intern Med J"},{"issue":"8","key":"10.1016\/j.vaccine.2023.06.039_b0110","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.vaccine.2023.06.039_b0115","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1111\/all.14747","article-title":"Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice","volume":"76","author":"Santos","year":"2021","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.vaccine.2023.06.039_b0120","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1111\/all.15278","article-title":"Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?","volume":"77","author":"Eberlein","year":"2022","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.vaccine.2023.06.039_b0125","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.semarthrit.2020.06.012","article-title":"COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients","volume":"50","author":"Ramirez","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2023.06.039_b0130","unstructured":"European-Commission. Article 29 data protection working party (0829\/14\/EN WP216). In: European-Commission, ed. 0829\/14\/EN WP216; 2014."},{"key":"10.1016\/j.vaccine.2023.06.039_b0135","unstructured":"Pawankar R, Canonica G, Holgate S, Lockey R, Blaiss MJMWAO. WAO white book on allergy: update 2013; 2013."},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.039_b0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cyto.b.21264","article-title":"Evaluation of basophil activation test in suspected food hypersensitivity","volume":"92","author":"Pignatti","year":"2017","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.039_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.05.020","article-title":"Optimizing investigation of suspected allergy to polyethylene glycols","volume":"149","author":"Bruusgaard-Mouritsen","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.039_b0150","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaip.2017.10.038","article-title":"Methodological cutoff of basophil activation test and basophil activation test diagnostic value","volume":"6","author":"Dreborg","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.vaccine.2023.06.039_b0155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11882-016-0633-6","article-title":"Pros and cons of clinical basophil testing (BAT)","volume":"16","author":"Hoffmann","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.039_b0160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/cid\/ciab518","article-title":"Incidence and characteristics of delayed injection site reaction to the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (Moderna) in a Cohort of hospital employees","volume":"74","author":"Jacobson","year":"2022","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"6","key":"10.1016\/j.vaccine.2023.06.039_b0165","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/cea.13880","article-title":"Adverse reactions to COVID-19 vaccines: A practical approach","volume":"51","author":"Rutkowski","year":"2021","journal-title":"Clin Exp Allergy: J Br Soc Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.039_b0170","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","article-title":"Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents","volume":"9","author":"Garay","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"issue":"18","key":"10.1016\/j.vaccine.2023.06.039_b0175","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMc2111452","article-title":"Rare skin reactions after mRNA vaccination, similar to Jones-Mote Basophil responses","volume":"385","author":"Askenase","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.039_b0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2009.10.007","article-title":"Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a","volume":"128","author":"Ali","year":"2010","journal-title":"Immunol Lett"},{"issue":"6","key":"10.1016\/j.vaccine.2023.06.039_b0185","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cea.13874","article-title":"Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine","volume":"51","author":"Sellaturay","year":"2021","journal-title":"Clin Exp Allergy: J Br Soc Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.039_b0190","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jconrel.2012.02.029","article-title":"Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: a porcine model","volume":"160","author":"Szebeni","year":"2012","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.039_b0195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41565-022-01071-x","article-title":"Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines","volume":"17","author":"Szebeni","year":"2022","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.039_b0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.alit.2021.01.005","article-title":"Activated steady status and distinctive FcepsilonRI-mediated responsiveness in basophils of atopic dermatitis","volume":"70","author":"Imamura","year":"2021","journal-title":"Allergol Int: Off J Japanese Soc Allergol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.039_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102790","article-title":"Basophils in autoimmunity: Systemic lupus erythematosus and more?","volume":"20","author":"Poddighe","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.039_b0210","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1038\/s41598-017-08516-7","article-title":"Basophils contribute to pristane-induced Lupus-like nephritis model","volume":"7","author":"Dema","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.039_b0215","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1159\/000481609","article-title":"Basophil recruitment to skin lesions of patients with systemic lupus erythematosus mediated by CCR1 and CCR2","volume":"43","author":"Pan","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.vaccine.2023.06.039_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.902494","article-title":"Role of basophils in a broad spectrum of disorders","volume":"13","author":"Miyake","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.039_b0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.135.2.235","article-title":"Basophilic leukocytes in allergic contact dermatitis","volume":"135","author":"Dvorak","year":"1972","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.039_b0230","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000110","article-title":"Th2 cytokines and atopic dermatitis","volume":"2","author":"Brandt","year":"2011","journal-title":"J Clin Cell Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.039_b0235","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.immuni.2005.06.011","article-title":"Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells","volume":"23","author":"Mukai","year":"2005","journal-title":"Immunity"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:55Z","timestamp":1759404535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23007144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":47,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X23007144"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}